EUVIMEDEUVIMED entdecken
Crossref

Gut Microbiota-Derived butyric acid attenuates kidney stone formation in humans and mice

Masahiko Isogai, Shuzo Hamamoto, Rei Unno, Kazumi Taguchi, Atsushi Okada, Takahiro Yasui

Urolithiasis · 2025

DOI: 10.1007/s00240-025-01812-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urolithiasis, 2025. Verfasst von Masahiko Isogai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Butyric Acid, Kidney Calculi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Grants-in- Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Aichi Kidney Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndromes, particularly obesity, are associated with kidney stone formation (KSF). The gut microbiota and its metabolites, including butyrate, play critical roles in regulating inflammation and obesity-related disorders. In this study, using human tissue samples and in vivo mice experiments, we examined the effects of butyrate on KSF. We compared the gut microbiota of healthy individuals and patients with kidney stones, using 16 S rRNA gene sequencing. For in vivo analysis, five-week-old male C57BL/6J mice were administered butyric acid-supplemented water for 12 weeks, followed by intraperitoneal injection of glyoxylate (80 mg/kg) for 6 days to induce renal crystal formation (RCF). Patients with kidney stones exhibited reduced gut microbiota diversity (P = 0.037) and a lower abundance of butyrate-producing bacteria (P = 0.023) compared to healthy controls, although no significant differences were observed in the proportions of individual bacterial species. In mice, butyric acid administration significantly reduced RCF (P < 0.001). Moreover, butyric acid treatment attenuated inflammation, as evidenced by decreased expression of interleukin (Il)6 and C-C motif ligand 2 (Ccl2). The liver X receptor/retinoid X receptor (LXR/RXR) pathway was activated, as revealed by quantitative real-time polymerase chain reaction and RNA sequencing. Additionally, western blotting and transmission electron microscopy showed that butyric acid mitigated early mitochondrial and microvillar damage. In conclusion butyric acid protects against RCF by reducing inflammation and oxidative stress. This is the first report to elucidate the potential therapeutic role of butyrate, a gut microbiota-derived metabolite, based on both human and in vivo evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeButyric AcidKidney CalculiAnimalsMaleHumansMiceMice, Inbred C57BLDisease Models, AnimalGlyoxylatesKidneyMiddle AgedAdult

Stichwörter der Autor:innen

Butyric acidGut microbiotaInflammatory cytokinesKidney stone formationLXR/RXR pathwayRenal crystal formation

Substanzen

Butyric AcidGlyoxylatesglyoxylic acid

Autor:innen und Institutionen

  • Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.
  • Department Urology, Inabe General Hospital, 771 Ageki, Hokusei-cho, Inabe, 511- 0428, Japan.
  • Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. hamamo10@med.nagoya-cu.ac.jp.

Förderung

  • Grants-in- Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan
  • Aichi Kidney Foundation

Zitieren

APA

Isogai, M., Hamamoto, S., Unno, R., Taguchi, K., Okada, A., & Yasui, T. (2025). Gut Microbiota-Derived butyric acid attenuates kidney stone formation in humans and mice. Urolithiasis. https://doi.org/10.1007/s00240-025-01812-2

Vancouver

Isogai M, Hamamoto S, Unno R, Taguchi K, Okada A, Yasui T. Gut Microbiota-Derived butyric acid attenuates kidney stone formation in humans and mice. Urolithiasis. 2025. doi:10.1007/s00240-025-01812-2

BibTeX
@article{Isogai2025,
  author = {Isogai, Masahiko and Hamamoto, Shuzo and Unno, Rei and Taguchi, Kazumi and Okada, Atsushi and Yasui, Takahiro},
  title = {Gut Microbiota-Derived butyric acid attenuates kidney stone formation in humans and mice},
  journal = {Urolithiasis},
  year = {2025},
  doi = {10.1007/s00240-025-01812-2}
}
Kostenlos starten →